Results for:(60 found)
Apr 11, 2013 9:23AM on Top StocksBy Benzinga

Amgen, Celgene and Pharmacyclics see short interest drop recently.

Mar 28, 2013 10:50AM on Top StocksBy Benzinga

There's mixed interest in biotech, biopharmaceutical and emerging pharma companies.

Mar 12, 2013 12:03PM on Top StocksBy Motley Fool

To make the list, you have to look out for all your stakeholders, not just shareholders.

Mar 8, 2013 10:17AM on Top StocksBy Stock Traders Daily

Patent expirations are contributing to M&A fever in the biotech sector.

Feb 28, 2013 12:09PM on Top StocksBy TheStreet Staff

Pfizer has multiple health care businesses and Elan has Tysabri royalties and a would-be acquirer.

Feb 27, 2013 2:11PM on Top StocksBy Charley Blaine

The Dow jumps 175 points and is nearing its 2007 closing high as investors ignore the budget battles and focus on better economic reports. Health care is one of the top sectors this year.

Feb 27, 2013 1:19PM on Top StocksBy MSN Money Partner

LinkedIn is initiated with a 'buy,' and Nokia is upgraded to 'buy.'

Feb 13, 2013 4:46AM on Top StocksBy Gene Marcial

This biotech behemoth's appeal is its combined value-and-growth stock characteristics.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More